Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Prostaglandin-mediated vasodilation refers to the process by which prostaglandins induce the relaxation and widening of blood vessels. This mechanism plays a crucial role in regulating vascular tone, blood flow, and blood pressure. Prostaglandins such as PGE2 and PGI2 bind to specific G protein-coupled receptors (EP4 and IP, respectively) on vascular smooth muscle cells, leading to increased cAMP/cGMP, decreased intracellular calcium, and resultant vasodilation. This process is important in various physiological functions including blood flow regulation, blood pressure control, renal function, and prevention of thrombosis. Dysregulation can contribute to diseases such as hypertension, pulmonary arterial hypertension, and cardiovascular disease.
Vasodilation via prostaglandin receptor activation (EP4, IP), leading to increased cAMP/cGMP and smooth muscle relaxation.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Prostaglandin-Mediated Vasodilation (None).